Funder
National Health and Medical Research Council
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol 14 Suppl 4(Suppl 4):iv45–iv54
2. Seretny M, Currie GL, Sena ES et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470
3. Teng C, Cohen J, Egger S, Blinman PL, Vardy JL (2022) Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer. Support Care Cancer 30:33–47
4. Winters-Stone KM, Horak F, Jacobs PG et al (2017) Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J Clin Oncol 35(23):2604–2612
5. McCrary JM, Goldstein D, Trinh T et al (2019) Balance deficits and functional disability in cancer survivors exposed to neurotoxic cancer treatments. J Natl Compr Canc Netw 17(8):949–955
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献